Stress, Social Support, and Adjustment of Adolescents in Middle School by Wenz-Gross, Melodie, Siperstein, Gary N., Untch, Andrew S., Widaman, Keith F.

Get full text

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pa... by de Azambuja, Evandro, Dr, Holmes, Andrew P, PhD, Piccart-Gebhart, Martine, MD, Holmes, Eileen, PhD, Di Cosimo, Serena, MD, Swaby, Ramona F, MD, Untch, Michael, MD, Jackisch, Christian, MD, Lang, Istvan, MD, Smith, Ian, MD, Boyle, Frances, MBBS, Xu, Binghe, MD, Barrios, Carlos H, MD, Perez, Edith A, MD, Azim, Hatem A, MD, Kim, Sung-Bae, MD, Kuemmel, Sherko, MD, Huang, Chiun-Sheng, MD, Vuylsteke, Peter, MD, Hsieh, Ruey-Kuen, MD, Gorbunova, Vera, MD, Eniu, Alexandru, MD, Dreosti, Lydia, MD, Tavartkiladze, Natalia, MD, Gelber, Richard D, PhD, Eidtmann, Holger, MD, Baselga, José, MD

Get full text

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial by Smith, Ian, Prof, Procter, Marion, MSci, Gelber, Richard D, Prof, Guillaume, Sébastien, MSc, Feyereislova, Andrea, MD, Dowsett, Mitch, Prof, Goldhirsch, Aron, Prof, Untch, Michael, Prof, Mariani, Gabriella, MD, Baselga, Jose, Prof, Kaufmann, Manfred, Prof, Cameron, David, MD, Bell, Richard, Prof, Bergh, Jonas, Prof, Coleman, Robert, Prof, Wardley, Andrew, MD, Harbeck, Nadia, Prof, Lopez, Roberto I, MD, Mallmann, Peter, Prof, Gelmon, Karen, Prof, Wilcken, Nicholas, PhD, Wist, Erik, Prof, Sánchez Rovira, Pedro, MD, Piccart-Gebhart, Martine J, Prof

Get full text

Association of Pathologic Complete Response with Long-Term Survival Outcomes in Triple-Negative Breast Cancer: A Meta-Analysis by Huang, Min, O'Shaughnessy, Joyce, Zhao, Jing, Haiderali, Amin, Cortés, Javier, Ramsey, Scott D, Briggs, Andrew, Hu, Peter, Karantza, Vassiliki, Aktan, Gursel, Qi, Cynthia Z, Gu, Chenyang, Xie, Jipan, Yuan, Muhan, Cook, John, Untch, Michael, Schmid, Peter, Fasching, Peter A

Get full text

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26... by Gray, Richard, Liu, Zulian, Peto, Richard, Davies, Lucy, McGale, Paul, Pan, Hongchao, Taylor, Carolyn, Barlow, William, Bliss, Judith, Bruzzi, Paolo, Cameron, David, Fountzilas, George, Loibl, Sibylle, Martin, Miguel, Möbus, Volker, Nekljudova, Valentina, De Placido, Sabino, Untch, Michael, Norton, Larry, Burrett, Julie, Evans, Vaughan, Hills, Robert, James, Sam, Mannu, Gurdeep, Morris, Philip, Wang, Yaochen, Wang, Zhe, Gnant, Michael, Di Leo, Angelo, Dolci, Stella, Larsimont, Denis, Nogaret, Jean Marie, Piccart, Martine, Linn, Sabine, Peer, Petronella, Tjan-Heijnen, Vivianne, Vliek, Sonja, Slamon, Dennis, Bramwell, Vivien H, Chen, Bingshu, Chia, Stephen, Gelmon, Karen, Goss, Paul, Parulekar, Wendy, Pater, Joseph, Rakovitch, Eileen, Shepherd, Lois, Berry, Don, Broadwater, Gloria, Shan, Yi, Xu, Binghe, Zhao, Dong-Bing, Bartelink, Harry, Cufer, Tanja, Poortmans, Philip, Rutgers, Emiel, van de Velde, Cornelis, Carrasco, Eva, Costa, Serban, Gerber, Bernd, Jackisch, Christian, von Minckwitz, Gunter, Giuliano, Mario, De Laurentiis, Michele, Bamia, Christina, Mavroudis, Dimitris, A'Hern, Roger, Sadoon, Mohammad, Costantino, Joe, Dignam, James, Fisher, Bernard, Mamounas, Eleftherios P, Paik, Soon, Redmond, Carol, Wickerham, D Lawrence, Venturini, Marco, Pastorino, Simona, Sertoli, Mario Roberto, Albain, Kathy, Arriagada, Rodrigo, Bergsten Nordström, Elizabeth, Boccardo, Francesco, Coleman, Robert, Correa, Candace, Dowsett, Mitch, Ewertz, Marianne, Goldhirsch, Aron, Hill, Catherine, Jagsi, Reshma, Janni, Wolfgang, Mukai, Hirofumi, Ohashi, Yasuo, Pierce, Lori, Raina, Vinod, Ravdin, Peter, Rea, Daniel, Sparano, Joseph, Tutt, Andrew, Viale, Giuseppe, Zambetti, Milvia

Get full text

Risk-based decision-making in the treatment of HER2-positive early breast cancer: Recommendations based on the current state of knowledge by Jackisch, Christian, Cortazar, Patricia, Geyer, Charles E., Gianni, Luca, Gligorov, Joseph, Machackova, Zuzana, Perez, Edith A., Schneeweiss, Andreas, Tolaney, Sara M., Untch, Michael, Wardley, Andrew, Piccart, Martine

Get full text

CTNI-39. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA by Lassman, Andrew, Alexander, Brian, Berry, Donald, Berry, Nicholas, Buxton, Meredith, Colman, Howard, Gan, Hui, de Groot, John, de la Fuente, Macarena, Drappatz, Jan, Ducray, Francois, Ellingson, Benjamin, Gordon, Gary, Hyddmark, Emma, Johnson, Adam, Khasraw, Mustafa, Lee, Eudocia, Lim, Michael, McGlothlin, Anna, Mellinghoff, Ingo, Mikkelsen, Tom, Nghiemphu, Phioanh, Perry, James, Powell, Ashley, Sulman, Erik, Tanner, Krik, Untch, Sarah, Weller, Michael, Wen, Patrick, Wick, Antje, Yung, Alfred, Cloughesy, Timothy

Get full text

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting by Singh, Simron, Hope, Thomas A, Bergsland, Emily B, Bodei, Lisa, Bushnell, David L, Chan, Jennifer A, Chasen, Beth R, Chauhan, Aman, Das, Satya, Dasari, Arvind, Del Rivero, Jaydira, El-Haddad, Ghassan, Goodman, Karyn A, Halperin, Daniel M, Lewis, Mark A, Lindwasser, O Wolf, Myrehaug, Sten, Raj, Nitya P, Reidy-Lagunes, Diane L, Soares, Heloisa P, Strosberg, Jonathan R, Kohn, Elise C, Kunz, Pamela L

Get full text

LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA by Mellinghoff, Ingo K, Cloughesy, Timothy, Alexander, Brian, Berry, Donald A, Buxton, Meredith, Cavenee, Webster, Colman, Howard, de Groot, John, Ellingson, Benjamin M, Gordon, Gary B, Lassman, Andrew B, Lim, Michael, Khasraw, Mustafa, Perry, James, Sulman, Erik P, Weller, Michael, Wen, Patrick, Yung, W K Alfred, Berry, Nicholas, Graves, Todd, Detry, Michelle, Hyddmark, E M Viktoria, Johnsson, Adam, Kling, Heather, McGlothlin, Anna, Powell, Ashley, Untch, Sarah, Aquilanti, Elisa, Blondin, Nicholas, Boulmay, Brian, de la Fuente, Macarena, Drappatz, Jan, Jordan, Justin, Kaley, Thomas J, Lobbous, Mina, Mikkelsen, Tom, Newton, Herbert, Owen, Scott, Peters, Katherine, Schiff, David, Sherman, Wendy, Weathers, Shiao-Pei, Youssef, Michael, Friend, John, Lee, Eudocia

Get full text

Abstract OT1-08-09: CONTESSA: A multinational, multicenter, randomized, phase 3 registration study of tesetaxel plus a reduced dose of capecitabine in patients with HER2-, hormone... by O'Shaughnessy, Joyce, Piccart, Martine, Schwartzberg, Lee, Cortes, Javier, Harbeck, Nadia, Im, Seock-Ah, Rugo, Hope, Untch, Michael, Yardley, Denise, Bondarenko, Igor, Dieras, Veronique, Pegram, Mark, Kroll, Stew, O'Connell, Joseph, Vacirca, Jeff, Wei, Thomas, Tang, Kevin, Seidman, Andrew

Get full text

Abstract GS4-01: Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor + (HR+)... by O'Shaughnessy, Joyce, Schwartzberg, Lee, Piccart, Martine, Rugo, Hope S., Yardley, Denise A, Cortes, Javier, Untch, Michael, Harbeck, Nadia, Wright, Gail S., Bondarenko, Igor, Glaspy, John, Nowecki, Zbigniew, Kayali, Fadi, Chan, Arlene, Levy, Christelle, Liu, Mei-Ching, Kim, Sung-Bae, Lemieux, Julie, Manikhas, Alexey, Tolaney, Sara, Lim, Elaine, Gombos, Andrea, Stradella, Agostina, Pegram, Mark, Fasching, Peter, Mangel, Laszlo, Semiglazov, Vladimir, Dieras, Veronique, Gianni, Luca, Danso, Michael A, Vacirca, Jeff, Kroll, Stew, O'Connell, Joseph, Tang, Kevin, Wei, Thomas, Seidman, Andrew

Get full text

Autoimmunity and Benefit from Trastuzumab Treatment in Breast Cancer: Results from the HERA Trial by Sonnenblick, Amir, Bailey, Andrew, Uziely, Beatrice, Untch, Michael, Smith, Ian, Gianni, Luca, Baselga, Jose, Jackisch, Christian, Cameron, David, Bell, Richard, Zardavas, Dimitrios, Al-Sakaff, Nedal, Gelber, Richard D, Dowsett, Mitch, Leyland-Jones, Brian, Piccart-Gebhart, Martine J, DE Azambuja, Evandro

Get full text